<PAGE> 1
CIRCE BIOMEDICAL, INC.
One Ledgemont Center
128 Spring Street
Lexington, Massachusetts 02173
VIA EDGAR
Securities and Exchange Commission November 25, 1997
450 Fifth Street, N.W.
Judiciary Plaza
Washington, D.C. 20549
Attention: Joseph K. Pascale, Esq.
Mail Stop 7-6
Re: Circe Biomedical, Inc.- Registration Statement on Form S-1
(Registration No. 333-29751)
Dear Mr. Pascale:
Pursuant to Rule 477 of the Rules and Regulations promulgated under the
Securities Act of 1933, as amended (the "Act"), Circe Biomedical, Inc. (the
"Company") hereby respectfully requests the withdrawal of the above-referenced
registration statement. The Company requests such withdrawal because it believes
that conditions are not favorable to going forward at this time.
Any questions should be addressed to Lewis J. Geffen, Esq., at Mintz,
Levin, Cohn, Ferris, Glovsky and Popeo, P.C., One Financial Center, Boston,
Massachusetts 02111, telephone (617) 542-6000.
Thank you.
CIRCE BIOMEDICAL, INC.
By: /s/ LASZLO J. EGER
-----------------------------
Laszlo J. Eger
President and Chief Executive
Officer
cc: Robert B. Lamm, Esq.
Joseph Mullaney, Esq.
Lewis J. Geffen, Esq.